Acasti Pharma Stock Volatility

ACST Stock  USD 2.69  0.07  2.54%   
Acasti Pharma secures Sharpe Ratio (or Efficiency) of -0.0835, which signifies that the company had a -0.0835% return per unit of standard deviation over the last 3 months. Acasti Pharma exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Acasti Pharma's risk adjusted performance of 0.0225, and Mean Deviation of 1.88 to double-check the risk estimate we provide. Key indicators related to Acasti Pharma's volatility include:
60 Days Market Risk
Chance Of Distress
60 Days Economic Sensitivity
Acasti Pharma Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Acasti daily returns, and it is calculated using variance and standard deviation. We also use Acasti's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Acasti Pharma volatility.
  

ESG Sustainability

While most ESG disclosures are voluntary, Acasti Pharma's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Acasti Pharma's managers and investors.
Environmental
Governance
Social
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Acasti Pharma can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Acasti Pharma at lower prices. For example, an investor can purchase Acasti stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Acasti Pharma's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Acasti Stock

  0.64VRNA Verona Pharma PLCPairCorr
  0.63VTYX Ventyx Biosciences Downward RallyPairCorr

Moving against Acasti Stock

  0.7RVMD Revolution MedicinesPairCorr
  0.5MRK Merck Company Earnings Call Next WeekPairCorr
  0.43HOOK Hookipa PharmaPairCorr

Acasti Pharma Market Sensitivity And Downside Risk

Acasti Pharma's beta coefficient measures the volatility of Acasti stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Acasti stock's returns against your selected market. In other words, Acasti Pharma's beta of 0.41 provides an investor with an approximation of how much risk Acasti Pharma stock can potentially add to one of your existing portfolios. Acasti Pharma shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Acasti Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Acasti Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Acasti Pharma Demand Trend
Check current 90 days Acasti Pharma correlation with market (NYSE Composite)

Acasti Beta

    
  0.41  
Acasti standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  2.38  
It is essential to understand the difference between upside risk (as represented by Acasti Pharma's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Acasti Pharma's daily returns or price. Since the actual investment returns on holding a position in acasti stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Acasti Pharma.

Acasti Pharma Stock Volatility Analysis

Volatility refers to the frequency at which Acasti Pharma stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Acasti Pharma's price changes. Investors will then calculate the volatility of Acasti Pharma's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Acasti Pharma's volatility:

Historical Volatility

This type of stock volatility measures Acasti Pharma's fluctuations based on previous trends. It's commonly used to predict Acasti Pharma's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Acasti Pharma's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Acasti Pharma's to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Acasti Pharma Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Acasti Pharma Projected Return Density Against Market

Given the investment horizon of 90 days Acasti Pharma has a beta of 0.4087 . This suggests as returns on the market go up, Acasti Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Acasti Pharma will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Acasti Pharma or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Acasti Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Acasti stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Acasti Pharma has an alpha of 0.0336, implying that it can generate a 0.0336 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
Acasti Pharma's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how acasti stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Acasti Pharma Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Acasti Pharma Stock Risk Measures

Given the investment horizon of 90 days the coefficient of variation of Acasti Pharma is -1196.94. The daily returns are distributed with a variance of 5.65 and standard deviation of 2.38. The mean deviation of Acasti Pharma is currently at 1.5. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.59
α
Alpha over NYSE Composite
0.03
β
Beta against NYSE Composite0.41
σ
Overall volatility
2.38
Ir
Information ratio -0.0058

Acasti Pharma Stock Return Volatility

Acasti Pharma historical daily return volatility represents how much of Acasti Pharma stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 2.376% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.5859% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About Acasti Pharma Volatility

Volatility is a rate at which the price of Acasti Pharma or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Acasti Pharma may increase or decrease. In other words, similar to Acasti's beta indicator, it measures the risk of Acasti Pharma and helps estimate the fluctuations that may happen in a short period of time. So if prices of Acasti Pharma fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for Next Year
Selling And Marketing Expenses122.4 K116.3 K
Market Cap18.5 M17.5 M
Acasti Pharma's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Acasti Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Acasti Pharma's price varies over time.

3 ways to utilize Acasti Pharma's volatility to invest better

Higher Acasti Pharma's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Acasti Pharma stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Acasti Pharma stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Acasti Pharma investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Acasti Pharma's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Acasti Pharma's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Acasti Pharma Investment Opportunity

Acasti Pharma has a volatility of 2.38 and is 4.03 times more volatile than NYSE Composite. 21 percent of all equities and portfolios are less risky than Acasti Pharma. You can use Acasti Pharma to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Acasti Pharma to be traded at $2.58 in 90 days.

Significant diversification

The correlation between Acasti Pharma and NYA is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Acasti Pharma and NYA in the same portfolio, assuming nothing else is changed.

Acasti Pharma Additional Risk Indicators

The analysis of Acasti Pharma's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Acasti Pharma's investment and either accepting that risk or mitigating it. Along with some common measures of Acasti Pharma stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Acasti Pharma Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Acasti Pharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Acasti Pharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Acasti Pharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Acasti Pharma.
When determining whether Acasti Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Acasti Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Acasti Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Acasti Pharma Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acasti Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
For more information on how to buy Acasti Stock please use our How to Invest in Acasti Pharma guide.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Acasti Stock analysis

When running Acasti Pharma's price analysis, check to measure Acasti Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acasti Pharma is operating at the current time. Most of Acasti Pharma's value examination focuses on studying past and present price action to predict the probability of Acasti Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acasti Pharma's price. Additionally, you may evaluate how the addition of Acasti Pharma to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Is Acasti Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acasti Pharma. If investors know Acasti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acasti Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.68)
Revenue Per Share
0.005
Return On Assets
(0.08)
Return On Equity
(0.48)
The market value of Acasti Pharma is measured differently than its book value, which is the value of Acasti that is recorded on the company's balance sheet. Investors also form their own opinion of Acasti Pharma's value that differs from its market value or its book value, called intrinsic value, which is Acasti Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acasti Pharma's market value can be influenced by many factors that don't directly affect Acasti Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acasti Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acasti Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acasti Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.